Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors

Inhibitors of fibroblast growth factor receptor (FGFR) represent an outstanding treatment approach for selected patients with urothelial cancer (UC). These agents are changing the clinical approach to a subgroup of UC, the luminal-papillary subtype, characterized by FGFR mutations, fusions, or ampli...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Med Oncol
Huvudupphovsmän: Casadei, Chiara, Dizman, Nazli, Schepisi, Giuseppe, Cursano, Maria Concetta, Basso, Umberto, Santini, Daniele, Pal, Sumanta K., De Giorgi, Ugo
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2019
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6878604/
https://ncbi.nlm.nih.gov/pubmed/31803255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919890285
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk